| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/11/2002 | EP1238279A1 Helicobacter pylori antigens in blood |
| 09/11/2002 | EP1238116A1 Process for labeling a nucleic acid |
| 09/11/2002 | EP1238115A1 Process for labeling a ribonucleic acid, and labeled rna fragments which are obtained thereby |
| 09/11/2002 | EP1238114A2 Methods and compositions relating to electrical detection of nucleic acid reactions |
| 09/11/2002 | EP1238113A2 Supracolonic aerodigestive neoplasm detection |
| 09/11/2002 | EP1238111A1 Biochips, preparation and uses |
| 09/11/2002 | EP1238110A2 Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated rna decay |
| 09/11/2002 | EP1238106A2 Apparatus and methods for drug screening based 0on nucleic acid analysis |
| 09/11/2002 | EP1238105A2 Generation of single-strand circular dna from linear self-annealing segments |
| 09/11/2002 | EP1238103A2 Methods for disease detection |
| 09/11/2002 | EP1238102A2 Microbial polynucleotides expressed during infection of a host |
| 09/11/2002 | EP1238100A2 Polynucleotide amplification method |
| 09/11/2002 | EP1238095A2 Compositions and methods for caspase-induced apoptosis |
| 09/11/2002 | EP1238092A2 Bovine immunodeficiency virus (biv) based vectors |
| 09/11/2002 | EP1238091A2 Methods and compositions for the manufacture of replication incompetent adenovirus |
| 09/11/2002 | EP1238090A2 Optimized t-dna transfer and vectors therefor |
| 09/11/2002 | EP1238089A2 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
| 09/11/2002 | EP1238088A2 Insecticide targets and methods of use |
| 09/11/2002 | EP1238087A2 Porcine endovirus gag and env and diagnostic uses thereof |
| 09/11/2002 | EP1238086A1 Method of enhancing immune responses to herpes simplex virus vaccine |
| 09/11/2002 | EP1238085A2 Bacillus thuringiensis toxin active against formicidae (ant) |
| 09/11/2002 | EP1238084A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/11/2002 | EP1238083A2 Rad3 orthologue-1 and uses thereof |
| 09/11/2002 | EP1238082A2 Ifn-alpha homologues |
| 09/11/2002 | EP1238081A2 Device and method for accelerated hydration of dry chemical sensors |
| 09/11/2002 | EP1238080A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 09/11/2002 | EP1238079A2 Wasp family protein fragments, and use thereof |
| 09/11/2002 | EP1238078A2 Clasp-4 transmembrane protein |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
| 09/11/2002 | EP1238076A2 G protein-coupled receptor-like receptors and modulators thereof |
| 09/11/2002 | EP1238075A2 Chordin-like molecules and uses thereof |
| 09/11/2002 | EP1238073A2 A eag gene encoding for a potassium channel |
| 09/11/2002 | EP1238072A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 09/11/2002 | EP1238071A2 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s rrnas and their uses |
| 09/11/2002 | EP1238070A2 Therapeutically useful synthetic oligonucleotides |
| 09/11/2002 | EP1238069A2 Antisense oligonucleotides for metabotropic glutamate receptor type 1 (mglur1) |
| 09/11/2002 | EP1238068A1 Directed evolution of biosynthetic and biodegration pathways |
| 09/11/2002 | EP1238067A2 Functional genomics using zinc finger proteins |
| 09/11/2002 | EP1238066A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 09/11/2002 | EP1238065A2 Factor x analog with an improved ability to be actived |
| 09/11/2002 | EP1238064A2 Srik a novel cell cycle protein associated with rip3 |
| 09/11/2002 | EP1238063A2 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 09/11/2002 | EP1238062A1 Compositions and methods for halogenation reactions |
| 09/11/2002 | EP1238059A2 Long-term cell culture compositions and genetically modified animals derived therefrom |
| 09/11/2002 | EP1237930A2 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization |
| 09/11/2002 | EP1237926A1 Human antibodies as detection reagents |
| 09/11/2002 | EP1237925A1 MUTANT ER$g(a) AND TEST SYSTEMS FOR TRANSACTIVATION |
| 09/11/2002 | EP1237924A2 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation |
| 09/11/2002 | EP1237921A1 Umlr polypeptides |
| 09/11/2002 | EP1237919A1 Interferon-alpha induced gene |
| 09/11/2002 | EP1237918A2 A gene, disrupted in schizophrenia |
| 09/11/2002 | EP1237917A2 Protein c derivatives |
| 09/11/2002 | EP1237916A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 09/11/2002 | EP1237915A2 Polynucleotid encoding the rg1 polypeptide |
| 09/11/2002 | EP1237914A1 Methods for improving secondary metabolite production in fungi |
| 09/11/2002 | EP1237912A2 Five-helix protein |
| 09/11/2002 | EP1237910A2 Trp-protein-related mtr1 protein and dna sequence coding therefor |
| 09/11/2002 | EP1237909A2 Human g protein-coupled receptors |
| 09/11/2002 | EP1237906A2 Complementary peptide ligands generated from plant genomes |
| 09/11/2002 | EP1237901A1 28 human secreted proteins |
| 09/11/2002 | EP1237900A1 Subunit optimized fusion proteins |
| 09/11/2002 | EP1237655A2 Multilayered microfluidic devices for analyte reactions |
| 09/11/2002 | EP1237582A2 Methods for introducing genes into mammalian subjects |
| 09/11/2002 | EP1237572A2 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
| 09/11/2002 | EP1237568A1 A conjugate of a collagen ii-binding fragment and an arthritis-affecting pharmaceutical substance |
| 09/11/2002 | EP1237565A1 Betaglycan as an inhibin receptor and uses thereof |
| 09/11/2002 | EP1237564A1 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions |
| 09/11/2002 | EP1237541A2 Liposomes |
| 09/11/2002 | EP1237405A1 Atp-binding cassette transporter (abc1) modified transgenic mice |
| 09/11/2002 | EP1237403A1 Method of usinf mapk4 and orthologues thereof to control plant disease and plantgrowth |
| 09/11/2002 | EP1189944A4 Axor16, a g protein coupled receptor |
| 09/11/2002 | EP1178113A9 Plant protein with pyrroline-5-carboxylat-dehydrogenase activity |
| 09/11/2002 | EP1175431A4 Substrate including anionic detergent for purifying nucleic acid |
| 09/11/2002 | EP1173459A4 Codeinone reductase from alkaloid poppy |
| 09/11/2002 | EP1147409A4 Separation of charged particles by a spatially and temporally varying electric field |
| 09/11/2002 | EP1098991B1 Novel methods for the identification of ligand and target biomolecules |
| 09/11/2002 | EP1098667A4 Chelating systems for use in the delivery of compounds to cells |
| 09/11/2002 | EP0954527A4 Glycine transporter-transfected cells and uses thereof |
| 09/11/2002 | EP0944715B1 Pressure-mediated intracellular delivery of molecules or microparticles |
| 09/11/2002 | EP0870053A4 Metabolic engineering of polyhydroxyalkanoate monomer synthases |
| 09/11/2002 | EP0832098B1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
| 09/11/2002 | EP0808169A4 Programmed cell death genes and proteins |
| 09/11/2002 | EP0762870B1 Virosome-mediated intracellular delivery of therapeutic agents |
| 09/11/2002 | EP0708835B1 Fruit specific promoters |
| 09/11/2002 | CN2510500Y Plasma biogene injection device |
| 09/11/2002 | CN1369017A PCR-based detection and quantification of Tapesia yellundae and Tapesia acuformis |
| 09/11/2002 | CN1369016A Novel means of transformation of fungi and their use for heterologous protein production |
| 09/11/2002 | CN1369015A Recombinant anti-CD 40 antibody and uses thereof |
| 09/11/2002 | CN1369014A Production of proteins |
| 09/11/2002 | CN1369013A Monocellular or multicellular organisms for production of riboflavin |
| 09/11/2002 | CN1369012A Delta 6-acetylenase and delta-6 desaturase from ceratodon purpureus |
| 09/11/2002 | CN1369011A Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 09/11/2002 | CN1369010A Compositions affecting programmed cell death and their use in-modification of forestry plant development |
| 09/11/2002 | CN1369009A Modified chimeric polyeptides with improved pharmacokinetic properties |
| 09/11/2002 | CN1369007A Alkaline xyloglucanase from malbranchea |
| 09/11/2002 | CN1368978A Novel proteins and uses thereof |
| 09/11/2002 | CN1368888A Anti-human mitochondrial a denylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disaese |
| 09/11/2002 | CN1368885A Compositions and methods for identifying antigens which elicit an immune response |
| 09/11/2002 | CN1368843A Transgenic animals expressing salivary proteins |
| 09/11/2002 | CN1368842A Biodegradable high oxidative stability oils |